Nöel Milpied

1990–2023 年に発表

114
論文数
21,703
被引用数
86
h 指数
114
i10 指数

被引用数

Nöel Milpied の年別被引用数1948 年: 被引用 1 件1956 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 5 件1994 年: 被引用 15 件1995 年: 被引用 15 件1996 年: 被引用 23 件1997 年: 被引用 13 件1998 年: 被引用 25 件1999 年: 被引用 22 件2000 年: 被引用 54 件2001 年: 被引用 66 件2002 年: 被引用 117 件2003 年: 被引用 123 件2004 年: 被引用 92 件2005 年: 被引用 137 件2006 年: 被引用 126 件2007 年: 被引用 147 件2008 年: 被引用 159 件2009 年: 被引用 156 件2010 年: 被引用 162 件2011 年: 被引用 169 件2012 年: 被引用 136 件2013 年: 被引用 160 件2014 年: 被引用 120 件2015 年: 被引用 126 件2016 年: 被引用 125 件2017 年: 被引用 104 件2018 年: 被引用 97 件2019 年: 被引用 421 件2020 年: 被引用 494 件2021 年: 被引用 572 件2022 年: 被引用 454 件2023 年: 被引用 279 件2024 年: 被引用 464 件2025 年: 被引用 175 件2026 年: 被引用 1 件1949〜1955 年は被引用が無いため表示していません1957〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,380 件、この内訳の 25.4%フランス: 引用元論文 740 件、この内訳の 7.9%ドイツ: 引用元論文 721 件、この内訳の 7.7%イギリス: 引用元論文 579 件、この内訳の 6.2%イタリア: 引用元論文 559 件、この内訳の 6%中国: 引用元論文 460 件、この内訳の 4.9%スペイン: 引用元論文 414 件、この内訳の 4.4%オランダ: 引用元論文 314 件、この内訳の 3.3%カナダ: 引用元論文 298 件、この内訳の 3.2%スイス: 引用元論文 287 件、この内訳の 3%オーストラリア: 引用元論文 226 件、この内訳の 2.4%日本: 引用元論文 203 件、この内訳の 2.2%
0%25.4%その他 23.4%

分野

  • Medicine89.9%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Immunology and Microbiology4%
  • Agricultural and Biological Sciences0.3%
  • Environmental Science0.1%
  • Pharmacology, Toxicology and Pharmaceutics0.1%
  • その他0.9%

トピック

  • Lymphoma Diagnosis and Treatment10.9%
  • CAR-T cell therapy research9.7%
  • Hematopoietic Stem Cell Transplantation6.8%
  • Acute Myeloid Leukemia Research4.4%
  • Viral-associated cancers and disorders3.6%
  • Chronic Lymphocytic Leukemia Research3.5%
  • その他61.1%

共著者

全論文

検索で開く
  1. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 1,823

  2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2006 被引用: 2,085

  3. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 811

  4. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabio Ciceri, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Mohamad Mohty - Bone Marrow Transplantation 2020 被引用: 203

  5. Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

    著者: , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2015 被引用: 316

  6. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

    著者: , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2018 被引用: 188

  7. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Moreau, J-F Rossi, Guillaume Cartron, Nadine Morineau, J. L. Harousseau, Éric Jourdan, Μichael N. Alexis, François Dreyfus, Vincent Delwail, Jérôme Cornillon, Réda Garidi, Emmanuel Gyan, Philippe Colombat, Pascal Godemer - Leukemia 2014 被引用: 324

  8. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

    著者: , , , , , , , , , , , , , , , , - Blood 2016 被引用: 167

  9. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aspasia Stamatoullas, Peter Möeller, Martin J.S. Dyer, Christer Sundström, Christian Bastard, Hervé Tilly, Karen Leroy - American Journal of Hematology 2016 被引用: 110

  10. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL

    著者: , , , , , , , , , , , , , , , , , , , , , - Haematologica 2019 被引用: 87

  11. Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2017 被引用: 128

  12. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

    著者: , , , , , , , , , , , , , , - Leukemia 2012 被引用: 131

  13. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamad Mohty, Elena Oldani, Kim Orchard, Jakob Passweg, Rachel Pearce, Régis Peffault de Latour, Hélène A. Poirel, Tuula Rintala, J. Douglas Rizzo, Annalisa Ruggeri, Carla Sanchez-Martinez, Fermín Sánchez‐Guijo, Isabel Sánchez‐Ortega, M Trnková, David Valcárcel, Leonie Wilcox, Liesbeth C. de Wreede, John A. Snowden - Bone Marrow Transplantation 2023 被引用: 24

  14. A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac - Blood 2020 被引用: 69

  15. Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 273

  16. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Morel-Baccard, Anne Signori-Schmück, Sophie Alain, Sébastien Hantz, Joël Grosjean, Florence Morfin, Geneviève Billaud, Vinca Domenach, Patrice André, Marie-Paule Milon, Michel Segondy, Vincent Foulongne, G. Agius, A. Beby‐Defaux, Bruno Pozzetto, S. Pillet, Jean‐Michel Mansuy, C. Mengelle, S. Gaudio-Castelain, Alexandra Ducancelle, F. Lunel, Christopher Payan, S. Gouarin, A. Dewilde, Celine Bressolette, Marianne Coste‐Burel, Berthe‐Marie Imbert‐Marcille, L. Andreoletti, Nicolas Lévêque, Véronique Venard, Hélène Jeulin, S. Minjolle, Marie Gueudin, R. Colimon, Françoise Stoll‐Keller, Samira Fafi‐Kremer, Frédéric Dubois, Catherine Gaudy, Paul Dény, F. B. Vezinet, Nadhira Houhou, P. Honderlick, Marie‐Christine Mazeron, M. Leruez‐Ville, P. Vaghefi, Élisabeth Dussaix, Henri Agut, David Boutolleau, Claire Deback, Catherine Scieux, Jérôme Le Goff, D. Ducloux, Claire Vanlemmens, Fabrice Larosa, Martine Neau‐Cransac, Claire Dromer, E. Rosier, Pierre Merville, M Douillet, D. Morel, Karine Moreau, Séverine Martin, Marc‐Alain Billes, Nöel Milpied, R. Tabrizi, S. Vigouroux, Christian Mélot, P. Deteix, A.‐E. Heng, Léandre Mackaya ほか 91 名 - Journal of Antimicrobial Chemotherapy 2010 被引用: 163

  17. Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2022 被引用: 23

  18. Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    著者: , , , , , , , , - Clinical Infectious Diseases 2002 被引用: 848

  19. A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2011 被引用: 123

  20. Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

    著者: , , , , , , , , , , , , , , , , , , , , - Blood Advances 2017 被引用: 89

  21. Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation

    著者: , , , , , , , , , , , , , , , , - Cancer 2012 被引用: 80

  22. Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients

    著者: , , , , , , , , , , , - Blood 2012 被引用: 190

  23. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

    著者: , , , , , , , - Blood 2002 被引用: 188

  24. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 156